Dr. Rupesh Tarwala, MD

Dr. Tarwala practices at New York Bone and Joint Specialists in New York, New York.

Dr. Tarwala's NPI, 1801186515, was assigned on April 14, 2011. Dr. Tarwala holds New York license 281313.

Dr. Tarwala's primary practice is New York Bone and Joint Specialists, at 130 E 67th St, New York, NY 10065 in New York County. The practice phone is (212) 759-8899.

Dr. Tarwala's primary practice is New York Bone and Joint Specialists in New York, New York. Dr. Tarwala is also affiliated with Hospital for Special Surgery. The medical group on file is New York Bone & Joint Specialists. Dmand AI also links Dr. Tarwala to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tarwala practices, 4 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Tarwala's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Tarwala is licensed in New York.

CMS data shows 1,610 Medicare services from Dr. Tarwala across 15 procedure codes in 2024, for 322 Medicare patients. Medicare paid $101,931 for them. Every service was in an office.

CMS counts 322 Medicare patients who saw Dr. Tarwala in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have arthritis, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tarwala's median patient age at 44, with 50% women.

In 2024, Dr. Tarwala wrote 537 Medicare Part D claims for 179 patients. 98% of them were for generic drugs. CMS names the drug for 474 of them, across 8 drugs with 11 or more claims each, at $6,476 in total drug cost. In 2023, CMS named 425 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Tarwala for performance year 2024, reported individually. Dr. Tarwala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of hip replacement by Dr. Tarwala, more than 55% of the clinicians it reports for that procedure.

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Tarwala, published from 2021 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Arthroplasty, Replacement, Knee. Dr. Tarwala has published most often in Clin Orthop Relat Res. Dr. Tarwala's most frequent co-authors are Zhinian Wan, MD and Nakul V. Karkare, MD.

CMS Open Payments shows 21 general payments to Dr. Tarwala from 7 drug and device companies from 2019 to 2024. Education make up the largest share, 79% of the total. Arthrex, Inc. paid the most, $2,619.